REMEVi semaglutide pricing
REMEVi does not price semaglutide by dose. It states one price that holds at every dose it dispenses, and publishes 2 such figures.
- How it prices
- One price at every dose — a policy, not a dose price
- Published figures
- 2 figures, read September 2026
- Compounded or branded
- The page does not say
- Dispensing pharmacy
- Not named on the semaglutide page
- Publishes its titration steps
- Yes — the seller prints the steps it will follow
- Pays this site
- No. Nothing, in any form
Your price never rises with your dose. Ever.
Figures quoted for any dose
REMEVi publishes 2 figures it says apply at every dose. Read these as a pricing policy rather than as dose steps: whatever separates the figures from each other, it is not milligrams.
| Figure | Cycle, in the seller’s words | What the seller says the figure covers | What kind of number it is |
|---|---|---|---|
| $189 | /mo | any dose — the seller guarantees the per-month price does not change with dose, across the published 0.25 mg to 2.0 mg escalation | a standing rate |
| $219 | /mo | any dose — the seller guarantees the per-month price does not change with dose, across the published 0.25 mg to 2.0 mg escalation | a standing rate |
Every figure is printed as REMEVi prints it, and was read September 2026, along with the basis it is quoted on. This site calls no figure here the cheapest, and prints no total this seller does not state itself.
What the figure covers
- medication
- provider follow-up
- shipping
- dose adjustments
- no membership fee
Those are our labels for what REMEVi’s page states, not its wording. The seller’s own words are on the page each figure was read from, linked below.
Our read
REMEVi states the flat-price guarantee three ways — “your price never rises with your dose, ever”, the intake copy, and a marquee reading “no dose upcharge” — and, unusually, publishes the escalation it is flat across, so the promise is anchored to a ladder a reader can see. It is one of five sellers here that publish a titration schedule.
The figures were read from the page REMEVi publishes them on in September 2026. Nothing on this page was carried over from another seller, another drug, or another site.
That link goes to its own semaglutide page — the page these figures were read from.
This record holds 2 figures read from one page. How the roster was built, and what a commercial relationship does and does not change, is on the disclosure page. The whole roster is on the reviews index and every figure across all sellers is on the cost page. Last checked September 2026.